E
Elo Life Systems
Biotechnology company that focuses on human health and wellness through food
About Elo Life Systems
Elo Life Systems, a biotechnology company, was spun out from Precision BioSciences in 2021 and is headquartered in Durham, North Carolina.
Read full description
The company focuses on developing next-generation food ingredients through molecular farming. This approach utilizes plants as bio-factories for producing specific proteins, enzymes, and other substances. Elo Life Systems aims to improve the nutritional profile and taste of food and beverage products. Their business model is centered on a B2B strategy, supplying these developed ingredients to companies in the food and beverage sector.
Elo Life Systems has two primary areas of focus. The first is the creation of a plant-based sweetener that is designed to replicate the taste of sugar without the caloric content. The second is in crop protection, where they are working on developing a solution to protect the Cavendish banana from a fungal disease that threatens its existence. By focusing on both ingredient enhancement and crop preservation, the company is positioning itself as a key player in the future of food technology and sustainable agriculture.
At a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Durham, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 63.2/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Crop Protection, Sugar, Spinout, Sustainable Development Goals, Biotech and Pharma, Climate Tech, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2024 | $21M | $123M | Novo Holdings · Hanwha · Alexandria Venture Investments · ACCELR8 | ↗ |
| SERIES A✓Equity / VC | Feb 2023 | $25M | $98M | DCVC · ACCELR8 · Novo Holdings | ↗ |
Growth signals
Latest recorded traffic for Elo Life Systems is 440 monthly website visits, down 80.9% over the last three months. Elo Life Systems's team declined 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
DCVC
ACCELR8
Novo Holdings
Hanwha
Alexandria Venture Investments
DCVC Bio
Other known investors2 additional known investors
Precision BioSciences
KdT Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elo Life Systems on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elo Life Systems’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.